Although NLRP3 is a well-known instigator of type 2 diabetes, the possibility that the IL-9 pathway could exert its protective effects by regulating the NLRP3 inflammasome has not been investigated thus far. This evidence concerns the gene IL9 and type 2 diabetes mellitus.